Alemtuzumab
Alemtuzumab is listed in the FDA National Drug Code directory with 4 NDC codes. Available dosage form: solution.
Drug details
- Generic Name
- Alemtuzumab
- Sponsor
- Boehringer Ingelheim Pharma GmbH And Co. KG
- NDC Codes
- 4
- Dosage Forms
- SOLUTION
- Active Ingredients
- ALEMTUZUMAB
Indications and Usage
1 INDICATIONS AND USAGE CAMPATH is indicated as a single agent for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). CAMPATH is a CD52-directed cytolytic antibody indicated as a single agent for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). ( 1 )